Swedish Orphan Biovitrum AB (OTCPK:BIOVF)
$ 31.38 -0.63 (-1.97%) Market Cap: 10.45 Bil Enterprise Value: 12.07 Bil PE Ratio: 31.90 PB Ratio: 3.01 GF Score: 90/100

Swedish Orphan Biovitrum AB (publ) Capital Markets Day Transcript

Dec 10, 2020 / 12:00PM GMT
Release Date Price: $19.81
Paula Treutiger;publ;Head of Corporate Communications;IR;Guido Oelkers
Swedish Orphan Biovitrum AB;Swedish

()-&

Welcome to Sobi's Capital Markets Day 2020. Thank you, all, for joining us today. A warm welcome to all viewers and also everyone that is participating over the phone. I am Paula Treutiger, Head of Communications and Investor Relations. Please pay attention to our forward-looking statements.

Today, you will hear from CEO, Guido Oelkers; Ravi Rao, Head of R&D; Norbert Oppitz, Head of Immunology and International; and finally, CFO, Henrik Stenqvist. They will give you an update on Sobi's future growth potential and also financially.

You see the agenda on the screen. After the first 2 presentations, we will have a break. After, we continue. We will end with a Q&A session and aim to finish at 4:00 o'clock.

In order to ask questions, you need to dial in on the conference call or send in your questions via the webcast site.

With that, I would like to hand over to Guido.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot